[Antidiuretic effect in diabetes insipidus after p-carboxy-benzolsulfo-di-n-butylamide (longacid)].
D050034:Antidiuretic Agents; D003919:Diabetes Insipidus / Q000628:therapy*; D020790:Diabetes Insipidus, Neurogenic; D006801:Humans; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*
D050034:Antidiuretic Agents; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide
DIABETES INSIPIDUS/therapy; SULFONAMIDES/therapeutic use
Antidiuretischer Effekt bei Diabetes insipidus nach p-Carboxy-benzolsulfo-di-n-butylamid (Longacid).